SCHEMBL5589677

SCHEMBL5589677

COc1cc(C)c(O)c(O)c1C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.52
MAPT P10636 4/20 0.45
POLB P06746 2/20 0.45
GFER P55789 2/20 0.45
HPGD P15428 2/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
NPSR1 Q6W5P4 1/20 0.45
FASN P49327 1/20 0.43
ALOX5 P09917 2/20 0.41
PTGS2 P35354 2/20 0.41
PTGS1 P23219 1/20 0.41
EGFR P00533 1/20 0.41
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
LMNA P02545 2/20 0.39
CA12 O43570 1/20 0.39
CA3 P07451 1/20 0.39
PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24811429 0.86 CYP3A4 (0.57) CYP3A4MAPTPOLBGFERHPGD
SCHEMBL24407972 0.86 CYP3A4 (0.47) CYP3A4MAPTPOLBGFERHPGD
SCHEMBL21002138 0.84 CYP3A4 (0.50) CYP3A4MAPTPOLBGFERHPGD
SCHEMBL14511731 0.82 CYP3A4 (0.50) CYP3A4MAPTPOLBGFERHPGD
SCHEMBL5518244 0.81 CYP3A4 (0.52) CYP3A4MAPTHPGDFASNALOX5
SCHEMBL1808984 0.79 EPHX2 (0.49) CYP3A4MAPTPOLBGFERHPGD
SCHEMBL4127825 0.79 MAPT (0.54) CYP3A4MAPTPOLBTDP1ALOX5
SCHEMBL25329804 0.79 FASN (0.42) CYP3A4MAPTPOLBGFERHPGD
SCHEMBL14511728 0.78 FASN (0.43) CYP3A4MAPTPOLBGFERHPGD
SCHEMBL5589851 0.77 KDM4E (0.40) CYP3A4MAPTPOLBHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 CYP3A4 1449/4885MAPT 585/4885POLB 1104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.